Table 6 Severity of allergy in allergic patients vs. healthy controls
From: Prospective validation of the “rhino conjunctivitis allergy-control-SCORE©” (RC-ACS©)
Allergic patients | Healthy controls | |||||
|---|---|---|---|---|---|---|
Criterion | n | Mean ± SD | Median [range] | n | Mean ± SD | Median [range] |
RC-ACS© (units) | 80 | 4.3 ± 3.0 | 3.7 [0.0; 14.1] | 40 | 0.2 ± 0.5 | 0.0 [0.0; 2.9] |
E-ACS© (units) | 80 | 1.2 ± 1.3 | 0.9 [0.0; 5.1] | 40 | 0.0 ± 0.2 | 0.0 [0.0; 1.0] |
N-ACS© (units) | 80 | 3.0 ± 2.1 | 3.0 [0.0; 9.0] | 40 | 0.1 ± 0.3 | 0.0 [0.0; 1.9] |
Global Assessment of Severity of Allergy (Rating Scale 1-10) | 80 | 3.6 ± 1.6 | 3.6 [1.0; 7.1] | 40 | 1.1 ± 0.2 | 1.0 [1.0; 2.3] |
Quality of Life (RQLQ total score) | 79 | 1.9 ± 1.1 | 1.8 [0.2; 4.1] | - | n.a. | n.a. |
Medical Consultations due to allergy in the last 12 months | 78 | 1.7 ± 2.5 | 1.0 [0.0; 12.0] | - | n.a. | n.a. |
Non-productive days due to allergy in the last 12 months | 80 | 0.6 ± 2.5 | 0.0 [0.0; 15.0] | - | n.a. | n.a. |